What are the Limitations of Using Autoantibodies as Cancer Biomarkers?
While promising, the use of autoantibodies as cancer biomarkers comes with certain limitations. These include variability in autoantibody levels among individuals, lack of specificity for different types of cancer, and the potential for false positives. Therefore, autoantibodies are often used in combination with other biomarkers and diagnostic tools to improve accuracy.
